Cinepazide maleate

Drug Profile

Cinepazide maleate

Alternative Names: Anjieli; Kelinao

Latest Information Update: 25 Sep 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sihuan Pharmaceutical Holdings Group
  • Class Antiparkinsonians; Neuroprotectants; Peripheral vasodilators
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Ischaemia

Most Recent Events

  • 31 Oct 2012 Sihuan Pharmaceutical initiates a post-marketing surveillance trial in Chinese patients (NCT01946919; PACER)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top